首页> 外文期刊>Brazilian Archives of Biology and Technology >Biological response of spontaneously hypertensive rats to the streptozotocin administration
【24h】

Biological response of spontaneously hypertensive rats to the streptozotocin administration

机译:自发性高血压大鼠对链脲佐菌素给药的生物学反应

获取原文
           

摘要

The sensitivity of adult spontaneously hypertensive rats (SHR) to the diabetogenic effect of streptozotocin (STZ) was studied. The animals were subdivided into three groups: control (citrate buffer), streptozotocin 40 mg/kg or 50 mg/kg, and general biologic parameters were analyzed, in addition to systolic blood pressure, blood glucose and insulin levels determinations. Both doses were able to induce hyperglycemia above 300 mg/dl; however, 50 mg/kg provoked a more pronounced physiological alterations in body weight, diuresis, water and food intake. There was no change on systolic blood pressure with either dose. Results suggested that SHRs did not need doses of streptozotocin above 40mg/kg in order to produce diabetes probably because this strain was much more sensible than normotensive rats. In addition, streptozotocin might be a drug choice to induce diabetes without provoking alterations in the blood pressure which allowed the use of this experimental model in the studies of induced hypertension-diabetes.
机译:研究了成年自发性高血压大鼠(SHR)对链脲佐菌素(STZ)的致糖尿病作用的敏感性。将动物分为三组:对照组(柠檬酸盐缓冲液),链脲佐菌素40 mg / kg或50 mg / kg,除了测定收缩压,血糖和胰岛素水平外,还分析了一般生物学参数。两种剂量均能诱发高于300 mg / dl的高血糖;然而,50 mg / kg在体重,利尿,水和食物摄入方面引起了更明显的生理变化。两种剂量的收缩压均无变化。结果表明,SHRs不需要剂量高于40mg / kg的链脲佐菌素即可产生糖尿病,可能是因为该菌株比正常血压的大鼠更敏感。另外,链脲佐菌素可能是诱导糖尿病而又不引起血压改变的药物选择,这使该实验模型可用于诱发高血压糖尿病的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号